Edge Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$266K Sell
4,113
-298
-7% -$19.5K 0.02% 280
2018
Q1
$316K Buy
4,411
+117
+3% +$8.42K 0.03% 260
2017
Q4
$323K Buy
4,294
+442
+11% +$32.3K 0.03% 256
2017
Q3
$280K Buy
3,852
+199
+5% +$14.3K 0.03% 271
2017
Q2
$270K Buy
3,653
+296
+9% +$22K 0.03% 280
2017
Q1
$245K Buy
3,357
+917
+38% +$64.2K 0.03% 297
2016
Q4
$159K Buy
+2,440
New +$167K 0.02% 331

Other funds holding CL

Edge Advisors's CL Position: Q2 2018 in Review

Edge Advisors reduced its Colgate-Palmolive (CL) stake by 6.8% in Q2 2018, selling an estimated $19.5K and leaving 4,113 shares worth $266K. The position accounts for 0.02% of the portfolio, ranked #280.

Edge Advisors first reported a position in CL in Q4 2016 and has held it in 7 quarters since. The position peaked at $323K in Q4 2017. 1,417 funds tracked by Wall St. Rank hold CL as of Q2 2018.

  • Edge Advisors held 4,113 shares of Colgate-Palmolive worth $266K as of Q2 2018.
  • Edge Advisors sold 298 Colgate-Palmolive shares in Q2 2018, an estimated $19.5K.
  • Colgate-Palmolive made up 0.02% of Edge Advisors's portfolio in Q2 2018, its #280 holding.
  • Edge Advisors first reported a position in Colgate-Palmolive in Q4 2016 and has held it in 7 quarters since.
  • Edge Advisors's Colgate-Palmolive position peaked at $323K in Q4 2017.
  • 1,417 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2018.

Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.